Pirfenidone Pirfact 267mg Tablets

Get a Price/Quote

MOQ : 10 Pieces

Pirfenidone Pirfact 267mg Tablets Specification

Salt Composition
Pirfenidone 267mg

Dosage Form
Tablet

Indication
Idiopathic Pulmonary Fibrosis (IPF)

Feature
Prescription medicine for the treatment of lung fibrosis

Ingredients
Pirfenidone

Application
Oral antifibrotic therapy

Physical Color/Texture
Film-coated tablet

Fermentation Smell
Odorless

Storage Instructions
Store in a cool, dry place below 25C. Protect from light.

Shelf Life
24 months

Packaging Size
30 tablets per box

Route of Administration
Oral

Prescription Required
Yes

Brand Name
Pirfact

Strength
267mg

Country of Approval
Globally approved in several countries (seen in image: Canada, EU, UK, USA, Australia)

Precautions
Use with caution in patients with liver or kidney impairment

Pirfenidone Pirfact 267mg Tablets About

Pirfenidone Pirfact 267mg Tablets stand as a rare and trending breakthrough in the treatment of Idiopathic Pulmonary Fibrosis (IPF). With a globally unassailable reputation-approved in Canada, the EU, UK, USA, and Australia-Pirfact offers an ineffable promise for patients exploring modern antifibrotic therapies. Each box contains 30 film-coated, odorless tablets, containing Pirfenidone 267mg. Designed for oral administration, this prescription medicine offers a towering approach to managing lung fibrosis. Use with caution in patients with liver or kidney issues. Store below 25C, protected from light.

Distinctive Features and Suitability for Use

Pirfenidone Pirfact 267mg Tablets are film-coated and virtually odorless, ensuring a comfortable oral experience. Specifically indicated for the management of idiopathic pulmonary fibrosis, these tablets are suitable for adult patients under physician guidance. Their effectiveness is underscored by global regulatory approvals and a robust safety profile. With a shelf life of 24 months, the clever packaging preserves their potency, making them reliable for both immediate and future use.

Timely Delivery and Domestic Market Support

Pirfact 267mg Tablets are dispatched promptly throughout the domestic market, ensuring reliable delivery timelines. Sample policies are available on request to accommodate medical institutions and distributors seeking trial quantities. Delivered to your location in secure packaging, these tablets cater to the needs of hospitals, pharmacies, and healthcare providers across India. Thorough tracking and customer support accompany each shipment, affirming confidence in every order placed.

FAQ's of Pirfenidone Pirfact 267mg Tablets:

Q: How should Pirfenidone Pirfact 267mg Tablets be taken?

A: Pirfenidone Pirfact 267mg Tablets are intended for oral administration and should be taken exactly as prescribed by your healthcare provider, usually three times daily with food.

Q: What is the main benefit of using Pirfenidone Pirfact for IPF?

A: Pirfact contains Pirfenidone, an antifibrotic agent, which helps slow disease progression in patients with idiopathic pulmonary fibrosis, potentially preserving lung function.

Q: When should I avoid taking Pirfenidone Pirfact 267mg Tablets?

A: Avoid using Pirfact if you have severe liver or kidney impairment, or if your doctor advises against its use due to potential health risks. Always consult your physician before starting therapy.

Q: Where has Pirfenidone Pirfact 267mg been approved for use?

A: Pirfact 267mg is globally approved in several countries, including Canada, the EU, UK, USA, and Australia, reflecting its established safety and efficacy profile.

Q: What precautions are necessary when using Pirfenidone Pirfact?

A: This medication should be used with caution in patients who have liver or kidney problems. Regular monitoring and dose adjustments by a healthcare provider may be necessary.

Q: How should Pirfenidone Pirfact 267mg Tablets be stored?

A: Store the tablets in a cool, dry place below 25C, protected from light. Follow the storage instructions on the packaging to maintain their effectiveness.

Tell us about your requirement